The Oral Delivery System of Modified GLP-1 by Probiotics for T2DM
The glucagon-like peptide-1 (GLP-1) is a peptide with incretin activity and plays an important role in glycemic control as well as the improvement of insulin resistance in type 2 diabetes mellitus (T2DM). However, the short half-life of the native GLP-1 in circulation poses difficulties for clinical...
Saved in:
Main Authors: | Qing Wang (Author), Haixin Guo (Author), Wenwei Mao (Author), Xiuping Qian (Author), Yangang Liu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Micro/Nanorobot: A Promising Targeted Drug Delivery System
by: Mengyi Hu, et al.
Published: (2020) -
Concept for a Unidirectional Release Mucoadhesive Buccal Tablet for Oral Delivery of Antidiabetic Peptide Drugs Such as Insulin, Glucagon-like Peptide 1 (GLP-1), and their Analogs
by: Anubhav Pratap-Singh, et al.
Published: (2023) -
Effect of GLP-1/GLP-1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis
by: Li Yang, et al.
Published: (2021) -
INITIATING PATIENTS ON GLP-1/COMBINED GLP-1 AND GIP AGONISTS: A QUALITY IMPROVEMENT PROJECT
by: Shreya Srivastava, MD, MPH
Published: (2024) -
Glucagon-like peptide 1 (GLP-1)
by: T.D. Müller, et al.
Published: (2019)